NMDA Receptor Antagonists and Pain: Ketamine

Veterinary Clinics of North America - Equine Practice

Volumn 26, Issue 3, 2010, Pages 565-578

  Muir, William W ^a  

^a Equine Anesthesia and Analgesia Consulting Services   (United States)

Author keywords

Allodynia; Drug infusion; Hypersensitivity; NMDA receptors

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL; ANIMAL DISEASE; DRUG ANTAGONISM; DRUG EFFECT; HORSE; HORSE DISEASE; METABOLISM; PAIN; REVIEW;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; HORSE DISEASES; HORSES; KETAMINE; PAIN; RECEPTORS, N-METHYL-D-ASPARTATE;

EQUIDAE;

EID: 78149262602     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2010.07.009     Document Type: Review

References (73)

1. Petrenko A.B., Yamakura T., Baba H., et al. The role of N-methyl-D-Aspartate (NMDA) receptors in pain: a review. Anesth Analg 2003, 97:1108-1116.
2. Carlton S.M., Hargett G.L., Coggeshall R.E. Localization and activation of glutamate receptors in unmyelinated and myelinated axons of rat glabrous skin. Neurosci Lett 1995, 197:25-28.
3. Latremoliere A., Woolf C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10(9):895-926.
4. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology 1995, 34:1219-1237.
5. Laube B., Hirai H., Sturgess M., et al. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 1997, 18:493-503.
6. Yamakura T., Shimoji K. Subunit-and site-specific pharmacology of the NMDA receptor channel. Prog Neurobiol 1999, 59:279-298.
7. DeKock M.F. The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Pract Res Clin Anaesthesiol 2007, 21:85-98.
8. Costigan M., Woolf C.J. Pain: molecular mechanisms. J Pain 2000, 1(Suppl 3):35-44.
9. Cheng H.T., Suzuki M., Hegarty D.M., et al. Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-D-aspartate receptor in spinal cord dorsal horn. Neuroscience 2008, 155(3):948-958.
10. Roh D., Seo H., Yoon S., et al. Activation of spinal a-2 adrenoceptors, but not u-opioid receptors, reduces the intrathecal n-methyl-D-aspartate-induced increase in spinal NR1 subunit phosphorylation and nociceptive behaviors in the rat. Anesth Analg 2010, 110:622-629.
11. Subramaniam K., Subramaniam B., Steinbrook R.A. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004, 99:482-495.
12. Cheng J., Cheng C., Yang J., et al. The antiallodynic action target of intrathecal gabapentin: Ca2+ channels, KATP channels or N-methyl-D-aspartate acid receptors. Anesth Analg 2006, 102:182-187.
13. Visser E., Schug S.A. The role of ketamine in pain management. Biomed Pharmacother 2006, 60:341-348.
14. Jones E., Vinuela-Fernandz I., Eager R.A., et al. Neuropathic changes in equine laminitis pain. Pain 2007, 132:321-331.
15. Clarke K.W., Hall L.W. " Xylazine" -a new sedative for horses and cattle. Vet Rec 1969, 85(19):512-517.
16. Muir W.W., Skarda R.T., Milne D.W. Evaluation of xylazine and ketamine hydrochloride for anesthesia in horses. Am J Vet Res 1977, 38(2):195-201.
17. Butera T.S., Moore J.N., Garner H.E., et al. Diazepam/xylazine/ketamine combination for short-term anesthesia in the horse. Vet Med Small Anim Clin 1978, 73(4):495-496.
18. Kawamata T., Omote H., Sonoda H., et al. Analgesic mechanisms of ketamine in the presence and absence of peripheral inflammation. Anesthesiology 2000, 93:520-528.
19. Koizuka S., Obata H., Sasaki M., et al. Systemic ketamine inhibits hypersensitivity after surgery via descending inhibitory pathways in rats. Can J Anaesth 2005, 52:498-505.
20. Costigan M., Scholz J., Woolf C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009, 32:1-32.
21. Yamashita K., Muir W.W. Intravenous anesthetic and analgesic adjunct to inhalation anesthesia. Equine anesthesia: monitoring and emergency therapy 2009, 261-272. Saunders Elsevier, St Louis (MO). 2nd edition. W.W. Muir, J.A. Hubbell (Eds.).
22. Mazar J., Rogachev B., Shked G., et al. Involvement of adenosine in the anti-inflammatory action of ketamine. Anesthesiology 2005, 102:1174-1181.
23. Filzek U., Fischer U., Ferguson J. Intravenous anaesthesia in horses: racemic ketamine versus S-(+)-ketamine. Pferdeheilkunde 2003, 19:501-506.
24. Rossetti R.B., Gaido Cortopassi S.R., Intelizano T., et al. Comparison of ketamine and S(+)-ketamine, with romifidine and diazepam, for total intravenous anesthesia in horses. Vet Anaesth Analg 2008, 35:30-37.
25. Larenza M.P., Knobloch M., Landoni M.F., et al. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration in Shetland ponies sedated with xylazine. Vet J 2008, 177(3):432-435.
26. Larenza M.P., Ringer S.K., Kutter A.P., et al. Evaluation of anesthesia recovery quality after low-dose racemic or S-ketamine infusions during anesthesia with isoflurane in horses. Am J Vet Res 2009, 70(6):710-718.
27. Schmitz A., Portier C.J., Thormann W., et al. Stereoselective biotransformation of ketamine in equine liver and lung microsomes. J Vet Pharmacol Ther 2008, 31(5):446-455.
28. Capponi L., Schmitz A., Thormann W., et al. In vitro evaluation of differences in phase 1 metabolism of ketamine and other analgesics among humans, horses, and dogs. Am J Vet Res 2009, 70(6):777-786.
29. Larenza M.P., Peterbauer C., Landoni M.F., et al. Stereoselective pharmacokinetics of ketamine and norketamine after constant rate infusion of a subanesthetic dose of racemic ketamine or S-ketamine in Shetland ponies. Am J Vet Res 2009, 70(7):831-839.
30. Larenza M.P., Landoni M.F., Levionnois O.L., et al. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies. Br J Anaesth 2007, 98(2):204-212.
31. Lankveld D.P., Driessen B., Soma L.R., et al. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses. J Vet Pharmacol Ther 2006, 29(6):477-488.
32. Ihmsen H., Geisslinger G., Schuttler J. Sterioselective pharmacokinetics of ketamine: R(-)-ketmaine inhibits the elimination of S(+)-ketmaine. Clin Pharmacol Ther 2001, 70:431-438.
33. Kaka J.S., Klavano P.A., Hayton W.L. Pharmacokinetics of ketmaine in the horse. Am J Vet Res 1979, 50:978-981.
34. Waterman A.E., Robertson S.A., Lane J.G. The pharmacokinetics of intravenously administered ketamine in the horse. Res Vet Sci 1987, 42:161-166.
35. White M., de Graaff P., Renshof B., et al. Pharmacokinetics of S(+) ketamine derived from target controlled infusion. Br J Anaesth 2006, 96:330-334.
36. Parsons L.E., Walmsley J.P. Field use of an acetylpromazine, methadone, ketamine combination for anaesthesia in the horse and donkey. Vet Rec 1982, 111(17):395.
37. Trim C.M., Adams J.G., Hovda L.R. Failure of ketamine to induce anesthesia in two horses. J Am Vet Med Assoc 1987, 190(2):201-202.
38. Muir W.W., Skarda R.T., Sheehan W. Evaluation of xylazine, guaifenesin, and ketamine hydrochloride for restraint in horses. Am J Vet Res 1978, 39(8):1274-1278.
39. Greene S.A., Thurmon J.C., Tranquilli W.J., et al. Cardiopulmonary effects of continuous intravenous infusion of guaifenesin, ketamine, and xylazine in ponies. Am J Vet Res 1986, 47(11):2364-2367.
40. Clarke K.W., Taylor P.M., Watkins S.B. Detomidine/ketamine anaesthesia in the horse. Acta Vet Scand Suppl 1986, 82:167-179.
41. Kaegi B. Schweiz Arch Tierheilkd 1990, 132(5):251-257. [in German].
42. McCarty J.E., Trim C.M., Ferguson D. Prolongation of anesthesia with xylazine, ketamine, and guaifenesin in horses: 64 cases (1986-1989). J Am Vet Med Assoc 1990, 197(12):1646-1650.
43. Wan P.Y., Trim C.M., Mueller P.O. Xylazine-ketamine and detomidine-tiletamine-zolazepam anesthesia in horses. Vet Surg 1992, 21(4):312-318.
44. Muir W.W., Gadawski J.E., Grosenbaugh D.A. Cardiorespiratory effects of a tiletamine/zolazepam-ketamine-detomidine combination in horses. Am J Vet Res 1999, 60(6):770-774.
45. Muir W.W., Lerche P., Robertson J.T., et al. Comparison of four drug combinations for total intravenous anesthesia of horses undergoing surgical removal of an abdominal testis. J Am Vet Med Assoc 2000, 217(6):869-873.
46. Hubbell J.A., Hinchcliff K.W., Schmall L.M., et al. Anesthetic, cardiorespiratory, and metabolic effects of four intravenous anesthetic regimens induced in horses immediately after maximal exercise. Am J Vet Res 2000, 61(12):1545-1552.
47. Muir W.W., Sams R. Effects of ketamine infusion on halothane minimal alveolar concentration in horses. Am J Vet Res 1992, 53(10):1802-1806.
48. Clarke K.W., Song D.Y., Alibhai H.I., et al. Cardiopulmonary effects of desflurane in ponies, after induction of anaesthesia with xylazine and ketamine. Vet Rec 1996, 139(8):180-185.
49. Yamashita K., Satoh M., Umikawa A., et al. Combination of continuous intravenous infusion using a mixture of guaifenesin-ketamine-medetomidine and sevoflurane anesthesia in horses. J Vet Med Sci 2000, 62(3):229-235.
50. Yamashita K., Muir W.W., Tsubakishita S., et al. Infusion of guaifenesin, ketamine, and medetomidine in combination with inhalation of sevoflurane versus inhalation of sevoflurane alone for anesthesia of horses. J Am Vet Med Assoc 2002, 221(8):1150-1155.
51. Umar M.A., Yamashita K., Kushiro T., et al. Evaluation of total intravenous anesthesia with propofol or ketamine-medetomidine-propofol combination in horses. J Am Vet Med Assoc 2006, 228(8):1221-1227.
52. Umar M.A., Yamashita K., Kushiro T., et al. Evaluation of cardiovascular effects of total intravenous anesthesia with propofol or a combination of ketamine-medetomidine-propofol in horses. Am J Vet Res 2007, 68(2):121-127.
53. Yamashita K., Wijayathilaka T.P., Kushiro T., et al. Anesthetic and cardiopulmonary effects of total intravenous anesthesia using a midazolam, ketamine and medetomidine drug combination in horses. J Vet Med Sci 2007, 69(1):7-13.
54. López-Sanromán F.J., Cruz J.M., Santos M., et al. Evaluation of the local analgesic effect of ketamine in the palmar digital nerve block at the base of the proximal sesamoid (abaxial sesamoid block) in horses. Am J Vet Res 2003, 64(4):475-478.
55. López-Sanromán J., Cruz J., Santos M., et al. Effect of alkalinization on the local analgesic efficacy of ketamine in the abaxial sesamoid nerve block in horses. J Vet Pharmacol Ther 2003, 26(4):265-269.
56. Gómez de Segura I.A., De Rossi R., Santos M., et al. Epidural injection of ketamine for perineal analgesia in the horse. Vet Surg 1998, 27(4):384-391.
57. Altunkaya A.H., Bayar A., Turan I.O., et al. The effect of intraarticular combinations of tramadol and ropivacaine with ketamine on postoperative pain after arthroscopic meniscectomy. Arch Orthop Trauma Surg 2010, 130:307-312.
58. Levionnois O.L., Menge M., Thormann W., et al. Effect of ketamine on the limb withdrawal reflex evoked by transcutaneous electrical stimulation in ponies anaesthetised with isoflurane. Vet J 2009, [Epub ahead of print].
59. Peterbauer C., Larenza P.M., Knobloch M., et al. Effects of a low dose infusion of racemic and S-ketamine on the nociceptive withdrawal reflex in standing ponies. Vet Anaesth Analg 2008, 35(5):414-423.
60. Knobloch M., Portier C.J., Levionnois O.L., et al. Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion. Toxicol Appl Pharmacol 2006, 216(3):373-386.
61. Lankveld D.P., Bull S., Van Dijk P., et al. Ketamine inhibits LPS-induced tumour necrosis factor-alpha and interleukin-6 in an equine macrophage cell line. Vet Res 2005, 36:257-262.
62. Grant I.S., Nimmo W.S., Clements J.A. Pharmacokinetics and analgesic effects of IM and oral ketamine. Br J Anaesth 1981, 53:805-810.
63. Himmelseher S., Durieux M.E. Ketamine for perioperative pain management. Anesthesiology 2005, 102(1):211-220.
64. Fielding C.L., Brumbaugh G.W., Matthews N.S., et al. Pharmacokinetics and clinical effects of a subanesthetic continuous rate infusion of ketamine in awake horses. Am J Vet Res 2006, 67(9):1484-1490.
65. Shulte H., Sollevi A., Segerdahl M. The synergistic effect of combined treatment of systemic ketamine and morphine on experimentally induced windup-like pain in humans. Anesth Analg 2004, 98:1574-1580.
66. Zhang G.H., Min S.S., Seol G.H., et al. Inhibition of the N-methyl-D-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery. Pain 2009, 143:233-237.
67. Lauline J., Maurette P., Corcuff J., et al. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 2002, 94:1263-1269.
68. Inturrisi C.E. The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance. Minerva Anestesiol 1994, 60:401-403.
69. Dabbagh A., Elyasi H., Razavi S.S., et al. Intravenous magnesium sulfate for post-operative pain in patients undergoing lower limb orthopedic surgery. Acta Anaesthesiol Scand 2009, 53:1088-1091.
70. Rees W.A., Harkins J.D., Woods W.E., et al. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurologicalneurologic effects in the horse. Equine Vet J 1997, 29(2):104-110.
71. Pippi N.L., Lumb W.V. Objective tests of analgesic drugs in ponies. Am J Vet Res 1979, 40(8):1082-1086.
72. Sotgiu M.L., Valente M., Storchi R., et al. Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain. Pharmacol Res 2009, 60(4):284-290.
73. Linardi R.L., Stokes A.M., Barker S.A., et al. Pharmacokinetics of the injectable formulation of methadone hydrochloride administered orally in horses. J Vet Pharmacol Ther 2009, 32(5):492-497.